Roctavian 2 × 1013 vector genomes (vg) per mL suspension for intravenous infusion Images
Generic Name: valoctocogene roxaparvovec
This medication has been identified as Roctavian 2 × 1013 vector genomes (vg) per mL suspension for intravenous infusion. It is supplied by BioMarin Pharmaceutical Inc.
Roctavian is used in the treatment of Hemophilia A and belongs to the drug class miscellaneous coagulation modifiers. Roctavian 2 × 1013 vector genomes (vg) per mL suspension for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Roctavian
- Generic Name
- valoctocogene roxaparvovec
- Strength
- 2 × 1013 vector genomes (vg) per mL suspension for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Miscellaneous coagulation modifiers
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- BioMarin Pharmaceutical Inc.
- National Drug Code (NDC)
- 68135-0927
More about Roctavian (valoctocogene roxaparvovec)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
